Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SkinStim
- Development stage
- Unknown
- Lead developer
- Leonhardt Ventures
- Modality
- Cell Therapies, Device-based Delivery → Drug Delivery Systems
- Administration
- Transdermal
01
Overview
SkinStim is a skin regeneration platform developed by Leonhardt Ventures that combines bioelectronic stimulation with biologics for dermatological and cosmetic applications. The system uses proprietary bioelectric signals to precisely control the expression and release of regenerative proteins, including stromal cell-derived factor 1 (SDF-1) for stem cell homing, tropoelastin for elasticity, and various growth factors such as PDGF, IGF-1, EGF, and HGF. The therapy is offered in three configurations: SkinStim (bioelectric stimulation only), SkinStim Plus Lite (bioelectric stimulation combined with platelet-rich fibrin and regenerative fluids), and SkinStim Plus (bioelectric stimulation combined with autologous stem cells and a full biologics cocktail). It is designed to treat skin aging, wounds, and other dermatological conditions by leveraging the synergistic effects of bioelectronic modulation and regenerative medicine.
- Brand names
- SkinStimSkinStim Plus LiteSkinStim Plus
- Other names
- bioelectronic skin regeneration system
Beyond the preview
Go deeper on SkinStim.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SkinStim.